Form D · Biotechnology
Ariel Precision Medicine, Inc.
Pittsburgh, PA · CIK 0001674590
Offering snapshot reported Jul 8, 2019 · SEC filing
- Reported sold
- $5.27M Offering amount: $8.77M
- Investors reported
- 20 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Jun 17, 2019 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Jul 8, 2019 | Initial | $5,270,657 | No comparison | 20 | SEC filing |
| May 27, 2016 | Initial | $125,000 | No comparison | 3 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-343652
Source: Form D, filed Jul 8, 2019. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Mary Del Brady | Director, Executive |
| Stephan Dietrich | Director |
| Jessica Gibson | Director, Executive |
| Christopher Moehle | Director |
| John T.B. Moore | Executive |
| Hank Safferstein | Director |
| David Smith | Director |
| David Whitcomb | Director |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
5750 Centre Avenue Suite 270
Pittsburgh, PA, 15206
Pittsburgh, PA, 15206